Using Tools of Neuroscience to Make Personalized Care a Reality in - - PowerPoint PPT Presentation

using tools of neuroscience to make personalized care a
SMART_READER_LITE
LIVE PREVIEW

Using Tools of Neuroscience to Make Personalized Care a Reality in - - PowerPoint PPT Presentation

Using Tools of Neuroscience to Make Personalized Care a Reality in Schizophrenia Cognitive impairment underlies functional outcome in SZ Clinical Daily Cognition Symptoms Functioning MODEST IMPROVEMENTS CLINICALLY RELEVANT IN COGNITION


slide-1
SLIDE 1

Using Tools of Neuroscience to Make Personalized Care a Reality in Schizophrenia

slide-2
SLIDE 2
slide-3
SLIDE 3
slide-4
SLIDE 4
slide-5
SLIDE 5
slide-6
SLIDE 6
slide-7
SLIDE 7

Cognitive impairment underlies functional outcome in SZ

Cognition Clinical Symptoms Daily Functioning

MODEST IMPROVEMENTS IN COGNITION CLINICALLY RELEVANT IMPROVEMENTS IN OUTCOMES

slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10

Testing the Information Processing Cascade Model

Early Auditory Information Processing (MMN) Cognition Clinical Symptoms Daily Functioning

Thomas et al. (2017)

slide-11
SLIDE 11

Disentangling Multivariate Relationships: Testing the Information Processing Cascade Model

Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Light GA. JAMA Psychiatry. 2017 Jan 1;74(1):37-46. doi: 10.1001/jamapsychiatry.2016.2980.

slide-12
SLIDE 12

Single-dose (1 pill) Malleability

100 200 300 400

  • 3
  • 2
  • 1

1 2

Time (ms)

Amplitude (µV)

SZ Placebo SZ Memantine 20mg

MMN is Sensitive to Initial Exposure to Memantine: 1 pill

Swerdlow NR, Bhakta SG, Chou HH, Talledo JA, Balvaneda B, Light GA (2015), Neuropsychopharmacology

slide-13
SLIDE 13

Thomas et al. (2017), JAMA Psychiatry.

Testing the Information Processing Cascade Model

Early Auditory Information Processing (MMN) Cognition Clinical Symptoms Daily Functioning a 1- uV change Supports d>0.78 change Time-course & requirements for change? Cognitive Training?

slide-14
SLIDE 14

“Experimental Medicine” Trial with a Nonpharmacologic Intervention: An Example using Auditory Targeted Cognitive Training (TCT)

  • Computerized approach to cognitive remediation
  • Aims to improve the accuracy and fidelity of auditory sensory information

processing

  • Capitalizes on “neuroplasticity based” learning mechanisms via exercises

that are: intensive, adaptive, rewarding

  • Place progressive demands on higher-order cognitive domains
  • Efficacious for improving cognition in psychosis patients at the group level

Tarasenko M, Perez VB, Pianka ST, Vinogradov S, Braff DL, Swerdlow NR, Light GA.(2016), Schizophrenia Research

slide-15
SLIDE 15
  • TCT improves verbal learning and memory in adult SZ outpatients.

Fisher M, et al. Am J Psychiatry. 2009

  • TCT improves verbal learning/memory in recent onset SZ outpatients.

Fisher M, et al. Schizophrenia Bulletin. 2015|

  • TCT improves verbal learning/memory in adolescents and young adults at clinical high risk

for psychosis. Loewy R, et al. Schizophrenia Bulletin. 2016

  • TCT improves verbal learning/memory and auditory hallucinations in treatment refractory

schizophrenia inpatients. *Thomas ML, Bismark AW, Joshi YB, Tarasenko M, Treichler EBH, Hochberger WC, Zhang W,

Nungaray J, Sprock J, Cardoso L, Tiernan K, Attarha M, Braff DL, Vinogradov S, Swerdlow N, Light GA. Schizophrenia Research. 2018

Previous Studies have Demonstrated Efficacy of TCT in Sz

* Top Research Finding of 2018, Brain & Behavior Research Foundation

slide-16
SLIDE 16

Challenges to overcome

TCT has largely been tested in academic labs TCT is time-intensive and requires resources TCT does not help all patients

slide-17
SLIDE 17

Are EE EEG m measur ures es acut utel ely y sens nsitive e to t

  • the

he ne neur ural systems eng ngaged b ed by 1h of T TCT exer ercises es? Do Does 30h of

  • f cogni
  • gnitive t

e traini ning “ ng “wor

  • rk” in

n treatmen ent refractory s schi hizophr

  • phren

enia a Inpa npatien ents? Do

  • EE

EEG cha hang nges fol

  • llowing

ng ini nitial e expos posur ure t to

  • TCT

pr predi dict f fut utur ure t e the herapeu eutic be bene nefit? ?

Testing the Effectiveness of TCT & Predictive Utility of EEG Biomarkers

slide-18
SLIDE 18

Sound Sweeps Memory Grid To-do List Training Fine Tuning Syllable Stacks Rhythm Recall

Auditory Targeted Cognitive Training: Brain Fitness Auditory Exercises

slide-19
SLIDE 19

Auditory Targeted Cognitive Training

slide-20
SLIDE 20

Auditory Targeted Cognitive Training

slide-21
SLIDE 21

Are EE EEG m measur ures es acut utel ely y sens nsitive e to t

  • the

he ne neur ural systems eng ngaged b ed by 1h of T TCT exer ercises es? Do Does 30h of

  • f cogni
  • gnitive t

e traini ning “ ng “wor

  • rk” in

n treatmen ent refractory s schi hizophr

  • phren

enia a Inpa npatien ents? Do

  • EE

EEG cha hang nges fol

  • llowing

ng ini nitial e expos posur ure t to

  • TCT

pr predi dict f fut utur ure t e the herapeu eutic be bene nefit? ?

Testing the Effectiveness of TCT & Predictive Utility of EEG Biomarkers

slide-22
SLIDE 22

Cha Chang nges i s in n Sour Source ce Con Contributions after er 1 1h h of

  • f Cogni

Cognitive e Trai aining

Perez VB et al (2019), Int J Psychophysiology Perez VB et al (2017), Neuropsychopharmacology

slide-23
SLIDE 23

Are EE EEG m measur ures es acut utel ely y sens nsitive e to t

  • the

he ne neur ural systems eng ngaged b ed by 1h of T TCT exer ercises es? Do Does 30h of

  • f cogni
  • gnitive t

e traini ning “ ng “wor

  • rk” in

n treatmen ent refractory s schi hizophr

  • phren

enia a Inpa npatien ents? Do

  • EE

EEG cha hang nges fol

  • llowing

ng ini nitial e expos posur ure t to

  • TCT

pr predi dict f fut utur ure t e the herapeu eutic be bene nefit? ?

Testing the Effectiveness of TCT & Predictive Utility of EEG Biomarkers

slide-24
SLIDE 24

Thomas et al, (2018)

SZ I Inpa npatien ents Matched hed on a at R Rando domization

  • n to T

TAU v

  • vs. TCT
slide-25
SLIDE 25

d = 0.82 p < 0.01

*

Verbal Learning TAU TCT

Post Baseline

TCT Enhances Verbal Learning in Severely Disabled SZ inpatients

Thomas et al, (2018)

slide-26
SLIDE 26

TAU TCT

TCT Reduces Hallucinations in Severely Disabled SZ inpatients

Auditory Hallucinations

Thomas et al, (2018)

slide-27
SLIDE 27

TAU TCT

TCT Improves Engagement in SZ inpatients

~1 extra total week of rehabilitation

+ 1.34 groups activities/wk + 0.58 ADLs/wk + 0.84 rehabilitation activities/wk

slide-28
SLIDE 28

Are EE EEG m measur ures es acut utel ely y sens nsitive e to t

  • the

he ne neur ural systems eng ngaged b ed by 1h of T TCT exer ercises es? Do Does 30h of

  • f cogni
  • gnitive t

e traini ning “ ng “wor

  • rk” in

n treatmen ent refractory s schi hizophr

  • phren

enia a Inpa npatien ents? Do

  • EE

EEG cha hang nges fol

  • llowing

ng ini nitial e expos posur ure t to

  • TCT

pr predi dict f fut utur ure t e the herapeu eutic be bene nefit? ?

Testing the Effectiveness of TCT & Predictive Utility of EEG Biomarkers

slide-29
SLIDE 29

Amplitude Changes After 1h Predicts Improvements in Verbal Learning After 30h

Hochberger et al (2019), Neuropsychopharmacology

slide-30
SLIDE 30

Amplitude Changes After 1h Predicts Reductions in Auditory Hallucinations After 30h

Hochberger et al (2019), Neuropsychopharmacology

slide-31
SLIDE 31

EEG Bi Biom

  • markers P

s Pred edict ct I Indi ndivi vidual Bene Benefits

Hochberger et al (in press)

slide-32
SLIDE 32

Swerdlow NR, Bhakta SG, Light GA (2018), Schizophrenia Research

Revised Neuroscience-Informed Experimental Medicine Approach

“IMPRECISE MEDICINE”

Intervention

Clinical Phenotype 12.5% “Responders” 87.5% “Non-Responders” TREATMENT FAILURE

Intervention

“PRECISION MEDICINE”

SCREEN FOR “BIOMARKER” Clinical Phenotype

Clinical Phenotype + “BIOMARKER”

100% “Responders” TREATMENT SUCCESS

slide-33
SLIDE 33

Lessons Learned and Caveats

  • This particular form of cognitive training is effective for improving cognitive, clinical, and psychosocial

functioning of patients, even those with long-standing illness.

  • Patients with greater severity of deficits benefited the most
  • Biomarkers measured
  • The exercises are not that much fun
  • Our sample size was small, others demonstrating similar effectiveness larger
  • Not all patients benefited
  • Complaints of daily cognitive problems were not improved, even among those with larger gains
  • Specific cognitive exercises and dose probably matters
  • Context of delivery and who administers it probably matters
  • Clinical stabilization first
  • Get the context right first – embedded within enriched psychosocial experiences.
slide-34
SLIDE 34

Ongoing Studies and Future Directions

– Accelerating drug development via translational neuroscience – Predicting development of illness in at risk individuals – Tracking progression of deficits across course of illness – Novel Analytics: Neural mechanisms, temporal dynamics, multivariate composite indices

  • Biomarker-guided assignment to treatments?
  • Biomarker in early and later phase clinical trials
  • Assessing early response to pharmacologic interventions: PACT
slide-35
SLIDE 35

Using Tools of Neuroscience to Make Personalized Care a Reality in Schizophrenia